首页> 外文期刊>Bone marrow transplantation >Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
【24h】

Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.

机译:在三例难治性严重再生障碍性贫血患儿中,以“大剂量”纯化的CD34 +细胞进行无关的外周血干细胞移植。

获取原文
获取原文并翻译 | 示例
       

摘要

Three children with refractory severe aplastic anemia were transfused with high numbers of unrelated matched (n = 2) or C-locus haploidentical mismatched (n = 1) CD34-selected peripheral blood stem cells in the absence of an HLA-identical family donor. Two leukaphereses of the donors yielded a median number of 10.1 x 10(10) nucleated cells (range 9.7-15.4) with a median number of 9.89 x 10(8) CD34+ cells (range 7.46-26.1) and a median percentage of CD34+cells of 0.98% (range 0.77-1.7). After positive selection by magnetic cell sorting the patients received a median of 14.3 x 10(6) CD34+ cells/kg (range 11.7-24.3) and of 1.3 x 10(4) CD3+ cells/kg (range 0.57-5.8). Median time to ANC >/=0.5 x 10(9)/l was 7 days (range 7-12) and to platelets >/=20 x 10(9)/l 13 days (range 13-27). Chimerism analysis of peripheral blood after transplantation revealed permanent 100% donor hematopoiesis in all patients. The patient with the C-locus haploidentical mismatch presented with acute GVHD (grade III-IV) of the skin, liver and lower gastrointestinal tract (onset day +40) and died despite intensive immunosuppressive treatment on day +238. The two survivors developed lymphopoietic recovery of B and T lymphocytes within 3 months after transplantation. To our knowledge this experience represents the first report of transplantation with unrelated CD34+ enriched peripheral blood stem cell in children with refractory severe aplastic anemia. Bone Marrow Transplantation (2000) 25, 513-517.
机译:在没有HLA相同家庭供者的情况下,向3例难治性严重再生障碍性贫血儿童输注了大量不相关的匹配(n = 2)或C位点单倍不匹配(n = 1)CD34选择的外周血干细胞。两个捐献者的白血球产生的中位数为10.1 x 10(10)有核细胞(范围为9.7-15.4),中位数为9.89 x 10(8)CD34 +细胞(范围为7.46-26.1),中位数为CD34 +单元格为0.98%(范围为0.77-1.7)。通过磁性细胞分选阳性选择后,患者的中位数为14.3 x 10(6)CD34 +细胞/ kg(范围11.7-24.3)和1.3 x 10(4)CD3 +细胞/ kg(范围0.57-5.8)。 ANC> / = 0.5 x 10(9)/ l的中位时间为7天(范围7-12),血小板> / = 20 x 10(9)/ l的中位数时间为13天(范围13-27)。移植后外周血的嵌合分析显示,所有患者均永久存在100%的供血造血功能。具有C位点单倍体错配的患者表现为皮肤,肝脏和下胃肠道的急性GVHD(III-IV级)(发病+40),尽管在第238天接受了强化免疫抑制治疗,但仍死亡。两名幸存者在移植后3个月内发展出B和T淋巴细胞的淋巴细胞恢复。据我们所知,这种经历代表了难治性再生障碍性贫血患儿首次使用不相关的CD34 +富集的外周血干细胞进行移植的报道。骨髓移植(2000)25,513-517。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号